2150 Stock Overview
CareNet, Inc. provides pharmaceutical sales support services for pharmaceutical companies in Japan.
Price History & Performance
|Historical stock prices|
|Current Share Price||JP¥943.00|
|52 Week High||JP¥2,162.50|
|52 Week Low||JP¥659.00|
|1 Month Change||8.02%|
|3 Month Change||8.89%|
|1 Year Change||-54.11%|
|3 Year Change||453.89%|
|5 Year Change||436.56%|
|Change since IPO||238.30%|
Recent News & Updates
|2150||JP Healthcare Services||JP Market|
Return vs Industry: 2150 underperformed the JP Healthcare Services industry which returned -44.8% over the past year.
Return vs Market: 2150 underperformed the JP Market which returned -4.7% over the past year.
|2150 Average Weekly Movement||11.8%|
|Healthcare Services Industry Average Movement||7.7%|
|Market Average Movement||4.2%|
|10% most volatile stocks in JP Market||8.5%|
|10% least volatile stocks in JP Market||2.3%|
Stable Share Price: 2150 is more volatile than 90% of JP stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: 2150's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
CareNet, Inc. provides pharmaceutical sales support services for pharmaceutical companies in Japan. It offers medical content services for doctors and healthcare professionals. The company offers CareNet.com, a membership-based medical and medical information site for daily clinical practice; PubMedCLOUD, a tool for searching and managing PubMed articles in Japanese; Doctors'Picks, a site where doctors gather specialized news that they want their doctors to read; CareNeTV, a clinical medicine channel; CareNet DVD, a clinical medical education DVD teaching material; and CareNet Career, a service that guides candidates for work in response to the needs of CareNet members, such as doctors for changing jobs and seeking employment.
CareNet Fundamentals Summary
|2150 fundamental statistics|
Is 2150 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2150 income statement (TTM)|
|Cost of Revenue||JP¥2.54b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 10, 2022
|Earnings per share (EPS)||35.69|
|Net Profit Margin||19.34%|
How did 2150 perform over the long term?See historical performance and comparison
0.6%Current Dividend Yield
Is 2150 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2150?
Other financial metrics that can be useful for relative valuation.
|What is 2150's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 2150's PE Ratio compare to its peers?
|2150 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
3902 Medical Data Vision
3733 Software Service
3939 Kanamic NetworkLTD
Price-To-Earnings vs Peers: 2150 is good value based on its Price-To-Earnings Ratio (26.4x) compared to the peer average (31.7x).
Price to Earnings Ratio vs Industry
How does 2150's PE Ratio compare vs other companies in the Asian Healthcare Services Industry?
Price-To-Earnings vs Industry: 2150 is good value based on its Price-To-Earnings Ratio (26.4x) compared to the JP Healthcare Services industry average (36.2x)
Price to Earnings Ratio vs Fair Ratio
What is 2150's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||26.4x|
|Fair PE Ratio||32.1x|
Price-To-Earnings vs Fair Ratio: 2150 is good value based on its Price-To-Earnings Ratio (26.4x) compared to the estimated Fair Price-To-Earnings Ratio (32.1x).
Share Price vs Fair Value
What is the Fair Price of 2150 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2150 (¥943) is trading below our estimate of fair value (¥4745.5)
Significantly Below Fair Value: 2150 is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: 2150 is poor value based on its PEG Ratio (1.1x)
Discover undervalued companies
How is CareNet forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2150's forecast earnings growth (24.1% per year) is above the savings rate (0.02%).
Earnings vs Market: 2150's earnings (24.1% per year) are forecast to grow faster than the JP market (8.9% per year).
High Growth Earnings: 2150's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2150's revenue (19.3% per year) is forecast to grow faster than the JP market (4.5% per year).
High Growth Revenue: 2150's revenue (19.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2150's Return on Equity is forecast to be high in 3 years time (25.7%)
Discover growth companies
How has CareNet performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2150 has high quality earnings.
Growing Profit Margin: 2150's current net profit margins (19.3%) are lower than last year (21.4%).
Past Earnings Growth Analysis
Earnings Trend: 2150's earnings have grown significantly by 39.7% per year over the past 5 years.
Accelerating Growth: 2150's earnings growth over the past year (13%) is below its 5-year average (39.7% per year).
Earnings vs Industry: 2150 earnings growth over the past year (13%) underperformed the Healthcare Services industry 27.7%.
Return on Equity
High ROE: 2150's Return on Equity (19%) is considered low.
Discover strong past performing companies
How is CareNet's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 2150's short term assets (¥9.0B) exceed its short term liabilities (¥1.6B).
Long Term Liabilities: 2150's short term assets (¥9.0B) exceed its long term liabilities (¥94.0M).
Debt to Equity History and Analysis
Debt Level: 2150 has more cash than its total debt.
Reducing Debt: 2150's debt to equity ratio has reduced from 12.6% to 0.1% over the past 5 years.
Debt Coverage: 2150's debt is well covered by operating cash flow (19511.1%).
Interest Coverage: 2150 earns more interest than it pays, so coverage of interest payments is not a concern.
Discover healthy companies
What is CareNet current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 2150's dividend (0.64%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.67%).
High Dividend: 2150's dividend (0.64%) is low compared to the top 25% of dividend payers in the JP market (3.71%).
Stability and Growth of Payments
Stable Dividend: 2150 is not paying a notable dividend for the JP market, therefore no need to check if payments are stable.
Growing Dividend: 2150 is not paying a notable dividend for the JP market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: 2150 is not paying a notable dividend for the JP market.
Cash Payout to Shareholders
Cash Flow Coverage: 2150 is not paying a notable dividend for the JP market.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Motoyasu Ohno (59 yo)
Mr. Motoyasu Ohno serves as Chairman at Medical Incubator Japan K.K. Mr. Ohno is the CareNet, Inc. and serves as its Chairman. He had been the President of CareNet, Inc. since October 2015.Mr. Ohno has be...
Experienced Management: 2150's management team is seasoned and experienced (8.2 years average tenure).
Experienced Board: 2150's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.6%.
CareNet, Inc.'s employee growth, exchange listings and data sources
- Name: CareNet, Inc.
- Ticker: 2150
- Exchange: TSE
- Founded: 1996
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: JP¥41.751b
- Shares outstanding: 44.27m
- Website: https://www.carenet.co.jp
Number of Employees
- CareNet, Inc.
- Sumitomo Fudosan Chiyoda Fujimi Bldg
- 1-8-19 Fujimi
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/28 00:00|
|End of Day Share Price||2022/06/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.